서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 42 of 42

Issue DateTitle / Author(s) / CitationFileAltmetrics
2010-09
Discrepancy between histology and culture in filamentous fungal infections
DOI
2010-11
The use of standardized patients to teach medical students clinical skills in ambulatory care settings
DOI
2011-10
Immunogenicity and safety of a single intramuscular dose of a diphtheria-tetanus toxoid (Td) vaccine (GC1107) in Korean adults
DOI
2012-01
Voriconazole-associated severe hyponatremia
DOI
2012-10
The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial
DOI
2016-02
Isolation of middle east respiratory syndrome coronavirus from a patient of the 2015 Korean outbreak
DOI
2016-07
Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy
DOI
2016-09
Viral Load Kinetics of MERS Coronavirus Infection
DOI
2017-06
Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies
DOI
2017-12
Risk factors for suboptimal drug concentration of posaconazole oral suspension in patients with hematologic malignancy
DOI
2018-01
Pre-clinical results in pig-to-non-human primate islet xenotransplantation using anti-CD40 antibody (2C10R4)-based immunosuppression
DOI
2018-02
Assessment of appropriateness of an initial dosing regimen of vancomycin and development of a new dosing nomogram

Yoon, Seonghae; Park, Kyoung Ryun; Lee, SeungHwan; Song, Sang-Hoon; Park, Wan Beom; Jang, In-Jin; Yu, Kyung-Sang

Basic and Clinical Pharmacology and Toxicology, Vol.122 No.2, pp.233-238

DOI
2018-02
Early therapeutic drug monitoring of posaconazole oral suspension in patients with hematologic malignancies
DOI
2018-05
18F-FDG PET and histopathologic findings in a patient with severe fever with thrombocytopenia syndrome
DOI
2018-07
The genetic polymorphism UGT1A4*3 is associated with low posaconazole plasma concentrations in hematological malignancy patients receiving the oral suspension
DOI
2019-02
An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus
DOI
2019-02
A Personalized CYP2C19 Phenotype-Guided Dosing Regimen of Voriconazole Using a Population Pharmacokinetic Analysis

Kim, Yun; Rhee, Su-jin; Park, Wan Beom; Yu, Kyung-Sang; Jang, In-Jin; Lee, Seunghwan

Journal of Clinical Medicine, Vol.8 No.2, p. 227

DOI
2019-06
Sequential emergence and wide spread of neutralization escape middle east respiratory syndrome coronavirus mutants, South Korea, 2015
DOI
2019-10
Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody
DOI
2020-02
Virus isolation from the first patient with SARS-CoV-2 in Korea
DOI
2020-05
Outbreak investigation of Serratia marcescens neurosurgical site infections associated with a contaminated shaving razors
DOI
2020-08
Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity
DOI
2020-12
Cell-Mediated Immunogenicity of Influenza Vaccination in Patients With Cancer Receiving Immune Checkpoint Inhibitors
DOI
2021-01
Stereotypic neutralizing V-H antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals
DOI
2021-03
Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody
DOI
2021-07
Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
DOI
2021-08
Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability
DOI
2022-02
Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study
DOI
2022-02
Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic
DOI
2022-03
Exploration for the effect of renal function and renal replacement therapy on pharmacokinetics of remdesivir and GS-441524 in patients with COVID-19: A limited case series
DOI
2022-03
Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity
DOI
2022-05
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
DOI
2022-05
Why are children less affected than adults by severe acute respiratory syndrome coronavirus 2 infection?

Kang, Chang Kyung; Shin, Hyun Mu; Park, Wan Beom; Kim, Hang-Rae

Cellular and Molecular Immunology, Vol.19 No.5, pp.555-557

DOI
2022-09
Longitudinal Analysis of Memory T-Cell Responses in Survivors of Middle East Respiratory Syndrome
DOI
2022-09
Persistent Antibody Responses Up to 18 Months After Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection
DOI
2022-11
Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer
DOI
2023-02
Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naïve individuals
DOI
2023-03
Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19
DOI
2023-04
Different degree of cytokinemia and T-cell activation according to serum IL-6 levels in critical COVID-19
DOI
2023-11
Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories
DOI
2024-02
Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic
DOI
2024-02
Clinical outcomes and immunological features of COVID-19 patients receiving B-cell depletion therapy during the Omicron era
DOI
1